U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232355) titled 'Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling' on Nov. 14.
Brief Summary: In May 2018, the World Health Organization (WHO) launched a strategy to eliminate cervical cancer. While this strategy seeks to achieve coverage of 70% in disease testing and 90% in treatment by 2030, it is estimated that these goals will not be achieved by most low- and middle- income (LMICs) countries until 2120 under existing conditions. Presently, more than 90% of worldwide cervical cancer cases occur in LMICs. To accelerate this timeline, there is an urgent need for accurate, affordable and rapid testing that can ...